(1)
Karimi, F.; Arya, A. SGLT2 Inhibitor-Induced Ketonemia and Its Related Metabolic and Anti-Inflammatory Impacts in Adult Patients With Type 2 Diabetes: SGLT2 Inhibitor-Induced Ketonemia in Type 2 Diabetes. Iran J Pharm Sci 2023, 19, 176-187.